Opportunity ID: 338417

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-23-010
Funding Opportunity Title: Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 28, 2022
Last Updated Date: Feb 28, 2022
Original Closing Date for Applications: Jul 15, 2022
Current Closing Date for Applications: Jul 15, 2022
Archive Date: Aug 20, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
Special district governments
For profit organizations other than small businesses
Independent school districts
County governments
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs in Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD). This FOA will support applications seeking to discover novel mechanisms mediated by ncRNAs, elucidate molecular, and cellular functions involved in the pathogenesis and progression of AD/ADRD.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-010.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or after January 25, 2022 PKG00272273 Jun 15, 2022 Jul 15, 2022 View

Package 1

Mandatory forms

338417 RR_SF424_5_0-5.0.pdf

338417 PHS398_CoverPageSupplement_5_0-5.0.pdf

338417 RR_OtherProjectInfo_1_4-1.4.pdf

338417 PerformanceSite_4_0-4.0.pdf

338417 RR_KeyPersonExpanded_4_0-4.0.pdf

338417 PHS398_ResearchPlan_4_0-4.0.pdf

338417 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

338417 RR_Budget_3_0-3.0.pdf

338417 RR_SubawardBudget30_3_0-3.0.pdf

338417 PHS398_ModularBudget_1_2-1.2.pdf

338417 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T14:39:09-05:00

Share This Post, Choose Your Platform!

About the Author: